38 results
424B5
FENC
Fennec Pharmaceuticals Inc
1 May 20
Prospectus supplement for primary offering
5:28pm
, the speed at which we can recruit patients to participate in testing our product candidate. We have experienced delays in some of our clinical trials … for PEDMARKTM, as well as:
our ability to design and successfully execute appropriate clinical trials;
our ability to recruit and enroll patients
424B5
hfmi7t
29 Apr 20
Prospectus supplement for primary offering
4:48pm
424B3
wxhcd31hmoo
21 Apr 14
Prospectus supplement
12:00am
424B3
bvyfw7 eilj
4 Apr 13
Prospectus supplement
12:00am
POS AM
fwu88w4 dxt
1 Apr 13
Prospectus update (post-effective amendment)
12:00am
424B3
a8y ibchn
14 Feb 11
Prospectus supplement
12:00am
S-1/A
q5bmx33
9 Feb 11
IPO registration (amended)
12:00am